Limei Sun
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Effects and risks of endocrine disrupting chemicals
Papers in
-
- RNA modifications and cancer 5
- Cell death mechanisms and regulation 4
- RNA Research and Splicing 3
- Angiogenesis and VEGF in Cancer 2
- Epigenetics and DNA Methylation 2
-
- MicroRNA in disease regulation 8
- Co-authors
- Huili Wang (8 shared papers)Xueshan Qiu (9 shared papers)Xuedong Wang (6 shared papers)Qingfu Zhang (4 shared papers)Yuhang Ling (6 shared papers)Wenting Luo (4 shared papers)Enhua Wang (4 shared papers)Enhua Wang (6 shared papers)
- Journals
- PLoS ONE (3 papers)Chemosphere (3 papers)Tumor Biology (2 papers)Apmis (1 paper)Journal of Histochemistry & Cytochemistry (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Limei Sun
27 papers receiving 945 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 248
- Health, Toxicology and Mutagenesis 138
- Immunology 153
- Pollution 86
- Molecular Biology 456
Countries citing papers authored by Limei Sun
This map shows the geographic impact of Limei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Sun more than expected).
Fields of papers citing papers by Limei Sun
This network shows the impact of papers produced by Limei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Sun. The network helps show where Limei Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 114 | |
| 2 | 2013 | 98 | |
| 3 | 2018 | 88 | |
| 4 | 2013 | 51 | |
| 5 | Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells. | 2014 | 51 |
| 6 | 2013 | 50 | |
| 7 | 2021 | 49 | |
| 8 | 2019 | 47 | |
| 9 | 2013 | 47 | |
| 10 | 2017 | 45 | |
| 11 | 2013 | 40 | |
| 12 | 2020 | 33 | |
| 13 | CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells. | 2015 | 33 |
| 14 | 2013 | 28 | |
| 15 | 2015 | 25 | |
| 16 | 2017 | 24 | |
| 17 | 2013 | 21 | |
| 18 | 2018 | 21 | |
| 19 | 2022 | 20 | |
| 20 | 2013 | 19 |
About Limei Sun
Limei Sun is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Immunology, having authored 28 papers that have together received 956 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (5 papers), Cell death mechanisms and regulation (4 papers), RNA Research and Splicing (3 papers), Cancer-related Molecular Pathways (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Epigenetics and DNA Methylation (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Cancer Research (248 citations), Health, Toxicology and Mutagenesis (138 citations), Immunology (153 citations), Pollution (86 citations) and Molecular Biology (456 citations). Limei Sun has collaborated with scholars based in China and United States. Frequent co-authors include Huili Wang, Xueshan Qiu, Xuedong Wang, Qingfu Zhang, Yuhang Ling, Wenting Luo, Enhua Wang, Enhua Wang, Danting Wang and Randy A. Dahlgren. Their work appears in journals such as PLoS ONE, Chemosphere, Tumor Biology, Apmis and Journal of Histochemistry & Cytochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.